HIGHLIGHTS
- who: CX and collaborators from the Bengbu Medical College, China Guangzhou Medical University, China have published the research work: Effect of CX3CL1/CX3CR1 gene polymorphisms on the clinical cacy of carboplatin therapy in Han patients with ovarian cancer, in the Journal: (JOURNAL)
- what: The authors collected relevant data of carboplatintreated ovarian cancer patients, such as age and disease type, and detected the related CX3CL1/CX3CR1 SNPs by Sequenom Mass ARRAY technology (based on the Sequenom platform) to evaluate whether they are efficacy-related alleles, determine the correlation between the above indicators and clinical efficacy, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.